Back to Search
Start Over
Calls to suspend European sales of erlotinib for lung cancer.
- Source :
-
The Lancet. Respiratory medicine [Lancet Respir Med] 2016 Sep; Vol. 4 (9), pp. 691. Date of Electronic Publication: 2016 Aug 01. - Publication Year :
- 2016
- Subjects :
- Antineoplastic Agents adverse effects
Drug and Narcotic Control
Drugs, Generic adverse effects
Erlotinib Hydrochloride adverse effects
Europe
Humans
Therapeutic Equivalency
Antineoplastic Agents therapeutic use
Drugs, Generic therapeutic use
Erlotinib Hydrochloride therapeutic use
Lung Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2619
- Volume :
- 4
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- The Lancet. Respiratory medicine
- Publication Type :
- Periodical
- Accession number :
- 27492661
- Full Text :
- https://doi.org/10.1016/S2213-2600(16)30230-2